Cancer cell senescence: a new frontier in drug development-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Cancer cell senescence: a new frontier in drug development

Published:2012-03 Issue:5-6 Volume:17 Page:269-276
ISSN:1359-6446
Container-title:Drug Discovery Today
language:en
Short-container-title:Drug Discovery Today

Author:

Cairney Claire J.,Bilsland Alan E.,Evans T.R. Jeffry,Roffey Jon,Bennett Dorothy C.,Narita Masashi,Torrance Christopher J.,Keith W. Nicol

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology

Reference54 articles.

1. Hallmarks of cancer: the next generation;Hanahan;Cell,2011

2. Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence;Narita;Cell,2003

3. Formation of MacroH2A-containing senescence-associated heterochromatin foci and senescence driven by ASF1a and HIRA;Zhang;Dev. Cell,2005

4. Epigenetic control of cellular senescence in disease: opportunities for therapeutic intervention;Atkinson;Expert Rev. Mol. Med.,2007

5. Living on a break: cellular senescence as a DNA-damage response;d’Adda di Fagagna;Nat. Rev. Cancer,2008

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ginsenoside Rg3: A Review of its Anticancer Mechanisms and Potential Therapeutic Applications;Current Topics in Medicinal Chemistry;2024-04

2. Preferential killing of melanoma cells by a p16-related peptide;Biology Open;2023-08-15

3. Palbociclib-Induced Cellular Senescence Is Modulated by the mTOR Complex 1 and Autophagy;International Journal of Molecular Sciences;2023-05-26

4. Tenglong Buzhong granules inhibits the growth of SW620 human colon cancer in vivo;J TRADIT CHIN MED;2022

5. Herbal medicine teng-long-bu-zhong-tang inhibits the growth of human RKO colorectal cancer by regulating apoptosis, senescence, and angiogenesis;World Journal of Traditional Chinese Medicine;2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3